Case Report: Integrated echocardiographic assessment guided Liwen procedure for treating obstructive hypertrophic cardiomyopathy with ventricular aneurysm
Hypertrophic cardiomyopathy (HCM) is a genetic myocardial disease, with an estimated incidence of 0.2%–6%, and is the main cause of sudden cardiac death (SCD) in young athletes. Left ventricular apical aneurysm (LVAA) is a rare subtype of HCM, accounting for about 5% of HCM patients, and has a highe...
Main Authors: | Rui Zhang, Fan Zhao, Jing Wang, Yahong Qin, Tingting Wang, Ai-Ai Chu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-11-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2023.1278457/full |
Similar Items
-
A rare manifestation of a known disease: Severe non-obstructive hypertrophic cardiomyopathy
by: Yalçın Velibey, et al.
Published: (2014-10-01) -
Hypertrophic cardiomyopathy with mid-ventricular obstruction and apical aneurysm
by: N.D. Oryshchyn, et al.
Published: (2016-11-01) -
The value of myocardial work in assessment of ventricular function in patients with non-obstructive hypertrophic cardiomyopathy
by: Chenguang Yang, et al.
Published: (2022-07-01) -
Ultrasound study of right ventricular myocardial perfusion and functional changes in hypertrophic cardiomyopathy
by: Shan Cao, et al.
Published: (2024-01-01) -
Troponin as ischemic biomarker is related with all three echocardiographic risk factors for sudden death in hypertrophic cardiomyopathy (ESC Guidelines 2014)
by: Rafał Hładij, et al.
Published: (2017-09-01)